iShares MSCI World ETF: A Six-Quarter Streak Meets a Triple Threat

The iShares MSCI World ETF is navigating a market defined by powerful, conflicting currents. While corporate America is on track for a sixth consecutive quarter of double-digit profit growth, the fund faces a trio of structural pressures that could force a massive portfolio reshuffle.

Corporate earnings provide a robust backdrop. According to FactSet, the S&P 500 is expected to post Q1 2026 earnings growth of 12.5%, marking the longest such streak in over a decade. The financial sector, a key pillar of the ETF’s portfolio, has been a standout. JPMorgan Chase kicked off reporting with a bang, posting record trading revenue. Its earnings per share of $5.94 and revenue of $50.54 billion, up 10% year-over-year, handily beat estimates. Goldman Sachs followed with strong results, reporting $17.23 billion in revenue and a net profit of $5.63 billion. All eyes are now on Morgan Stanley, which reports before the market opens with analysts forecasting $2.95 per share on $19.23 billion in revenue.

However, this earnings strength is tempered by cautious guidance and macroeconomic headwinds. JPMorgan’s management promptly lowered its full-year net interest income forecast from $104.5 billion to $103 billion, sending its shares down nearly 3%. The persistent inflation environment adds to the concern, with the US rate climbing to 3.3% in March, diminishing hopes for imminent Federal Reserve rate cuts.

Beyond the macro picture, three concrete challenges are converging on the world’s largest ETF. First, a fierce fee war is intensifying. Competitor Invesco slashed the management fee for its own MSCI World UCITS ETF to 0.05% in early April, making BlackRock’s iShares Core MSCI World ETF, with a total expense ratio of 0.24%, appear significantly more expensive. BlackRock counters by highlighting its fund’s tight tracking difference of just 0.02%, a factor that contributes to its Bronze rating from Morningstar.

Should investors sell immediately? Or is it worth buying MSCI World ETF?

Second, a major index overhaul looms. MSCI’s upcoming semi-annual review in May will introduce a new free-float classification system with three categories. Analysts expect this change to trigger far more substantial portfolio shifts than the relatively modest Q1 review, which saw 18 additions and 27 deletions.

Third, escalating trade tensions pose a direct risk. New US pharmaceutical tariffs set for late July 2026 will impose levies of 15% on imports from the EU, Japan, South Korea, and Switzerland. For companies without US pricing agreements, tariffs could soar to 100%. This policy is projected to add approximately 0.5 percentage points to inflation and squeeze margins in the healthcare sector.

These external pressures intersect with the ETF’s own structural vulnerability: extreme concentration. The technology sector alone accounts for over 26% of the portfolio, with just three stocks—Nvidia, Apple, and Microsoft—comprising 13.6% of the total allocation. This heavy reliance on tech, combined with the sector’s deep dependence on Asian supply chains amidst rising trade tensions, leaves the fund acutely exposed to interest rate shocks and geopolitical friction.

Technically, the fund is at a pivotal point, testing resistance at $190.18. A breakout could see it challenge the 52-week high of $192.84, while a fall below the $188.56 support level might signal a deeper pullback. The upcoming earnings reports from the three tech titans in the coming weeks will likely dictate this near-term direction, setting the stage for a volatile period of recalibration.